Patents by Inventor David George Potter

David George Potter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190241677
    Abstract: Antibodies that neutralize Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting the bone.
    Type: Application
    Filed: February 15, 2019
    Publication date: August 8, 2019
    Applicant: Lexicon Pharmaceuticals, Inc.
    Inventors: Robert Joseph Brommage, JR., Xiao Feng, Seokjoo Hong, Gregory Landes, Jeff Liu, David George Potter, David Reed Powell
  • Publication number: 20160152731
    Abstract: Antibodies that neutralize Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting the bone.
    Type: Application
    Filed: November 25, 2015
    Publication date: June 2, 2016
    Applicant: Lexicon Pharmaceuticals, Inc.
    Inventors: Robert Joseph Brommage, JR., Xiao Feng, Seokjoo Hong, Gregory Landes, Jeff Liu, David George Potter, David Reed Powell
  • Publication number: 20130302346
    Abstract: Antibodies that neutralize Notum Pectinacetylesterase are described, as well as compositions comprising them, and methods of their use to treat diseases and disorders affecting the bone.
    Type: Application
    Filed: November 22, 2011
    Publication date: November 14, 2013
    Applicant: LEXICON PHARMACEUTICALS, INC.
    Inventors: Robert Joseph Brommage, JR., Xiao Feng, Seokjoo Hong, Gregory Landes, Jeff Liu, David George Potter, David Reed Powell
  • Publication number: 20100017152
    Abstract: A non-contact apparatus is provided for monitoring the height of contents of a moving container, such as a beverage can 24 on a conveyor 14. The apparatus comprises non-contact ultrasonic wave generation means comprising a first electromagnetic acoustic transducer 16 disposed to one side of a container 24 being monitored and adapted to produce an ultrasonic wave pulse in the container, and non-contact ultrasonic wave detector means comprising a second electromagnetic acoustic transducer 18 adapted to detect an ultrasonic signal and to generate a detection signal dependent upon the ultrasonic signal which is detected, the detector means being disposed at a different position to the side of a container 24 from the generation means. The apparatus further including signal processing means 20 adapted to process the detection signal generated by the ultrasonic wave detector means using the difference in transit times for two waves to provide an indication of the level of the contents in the container 24.
    Type: Application
    Filed: June 11, 2007
    Publication date: January 21, 2010
    Inventors: Mark David George Potter, Steve Mark Dixon, John Reed, Stuart Mont Palmer
  • Publication number: 20080102520
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: February 17, 2006
    Publication date: May 1, 2008
    Inventors: Alejandro Abuin, Michael B. Burnett, Emily B. Cullinan, Gregory Donoho, Dorit B. Donoviel, Carl Johan Friddle, Glenn Friedrich, Brenda Gerhardt, Erin Hilbun, Yi Hu, Brian Mathur, Maricar Miranda, Michael C. Nehls, Boris Nepomnichy, David George Potter, David Reed Powell, Arthur T. Sands, John Scoville, Hong Sun, C. Alexander Turner, D. Wade Walke, Frank Wattler, Nathaniel L. Wilganowski, Xuanchuan Yu, Brian Zambrowicz
  • Publication number: 20040204580
    Abstract: The present invention relates to methods and compositions for the treatment of biological disorders regulatable by the controlled expression or inhibition of the described NHP.
    Type: Application
    Filed: May 11, 2004
    Publication date: October 14, 2004
    Inventors: C. Alexander Turner, Erin Hilbun, David George Potter
  • Patent number: 6790667
    Abstract: The present invention relates to methods and compositions for the treatment of biological disorders regulatable by the controlled expression or inhibition of the described NHP.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: September 14, 2004
    Assignee: Lexicon Genetics Incorporated
    Inventors: C. Alexander Turner, Jr., Erin Hilbun, David George Potter
  • Publication number: 20030144497
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: February 11, 2003
    Publication date: July 31, 2003
    Inventors: Gregory Donoho, Erin Hilbun, C. Alexander Turner, Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, David George Potter
  • Patent number: 6555669
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: April 29, 2003
    Assignee: Lexicon Genetics Incorporated
    Inventors: Gregory Donoho, Erin Hilbun, C. Alexander Turner, Jr., Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, David George Potter
  • Publication number: 20020098486
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: February 28, 2001
    Publication date: July 25, 2002
    Inventors: Gregory Donoho, Erin Hilbun, C. Alexander Turner, Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, David George Potter